CONTACT: LINDSAY RUNYAN
Iowa City IA 52242
(319) 335-9585; fax (319) 384-4638
Release: April 25, 2002
People with obsessive
compulsive disorder invited to participate in UI study
People with obsessive compulsive
disorder (OCD) are invited to participate in a University of Iowa Health Care
treatment study. The study will examine the effectiveness of a new medication
to treat OCD. Some participants will receive a placebo (inactive medication).
Participants must be between
the ages of 18 and 65 and cannot be abusing alcohol or drugs. Participants
must be able to remain free of any prescription or nonprescription psychotropic
drugs for two weeks, give prior consent to participate, and sign an informed
consent. Women must not be pregnant or planning to get pregnant during the
study period. The study will consist of a two to four- week, single-blind,
placebo screening period, 12 weeks of double-blind treatment, followed by
one week of placebo washout. The first visit includes a physical examination.
The follow-up visits involve assessment of the participant's disorder as well
as discussion of the medication and its side effects.
For more information, contact
the study's lead investigator, Donald W. Black, M.D., UI professor of psychiatry,
at (319) 353-4431.
of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver
College of Medicine and the UI Hospitals and Clinics and the patient care,
medical education and research programs and services they provide. Visit UI
Health Care online at www.uihealthcare.com.